Rankings
▼
Calendar
MIRM FY 2020 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$623,000
Operating Income
-$104M
Net Income
-$103M
EPS (Diluted)
$-4.09
Cash Flow
Operating Cash Flow
-$89M
Free Cash Flow
-$89M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$241M
Total Liabilities
$69M
Stockholders' Equity
$172M
Cash & Equivalents
$142M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$623,000
-$324,000
-92.3%
Operating Income
-$104M
-$55M
-90.5%
Net Income
-$103M
-$53M
-96.5%
← Q4 2019
All Quarters
Q1 2020 →